Incyte Genomics (INCY) Misses Q2 Views
Tweet
Share
E-mailGet Alerts INCY Hot Sheet
Price: $104.40 --0%
Financial Fact:
Selling, general and administrative: 75.78M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Financial Fact:
Selling, general and administrative: 75.78M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Incyte Genomics (NASDAQ: INCY) reported Q2 EPS of ($0.41), $0.05 worse than the analyst estimate of ($0.36). Revenue for the quarter came in at $16.8 million versus the consensus estimate of $19.17 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Incyte (INCY) PT Raised to $105 at Truist Securities
- Accenture (ACN) Tops Q3 EPS by 8c, Misses on Revenue; Offers FY26 EPS Guidance
- KB Home (KBH) Misses Q2 EPS by 2c; Offers Outlook
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
